BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
According to data as of March 2021, around six billion U.S. dollars were paid to Pfizer and BioNtech by the Biomedical Advanced Research and Development Authority of the United States to support the development of their COVID-19 vaccine. This statistic illustrates the BARDA funding for the development of select COVID-19 vaccines in the United States.